Log in

NASDAQ:GRTSGritstone Oncology News Headlines

$6.10
-0.16 (-2.56 %)
(As of 04/6/2020 06:07 AM ET)
Add
Compare
Today's Range
$5.68
Now: $6.10
$6.48
50-Day Range
$5.47
MA: $7.58
$10.45
52-Week Range
$5.42
Now: $6.10
$15.94
Volume162,705 shs
Average Volume191,568 shs
Market Capitalization$225.58 million
P/E RatioN/A
Dividend YieldN/A
Beta1.41

Headlines

Gritstone Oncology (NASDAQ GRTS) News Headlines

Source:
DateHeadline
Gilead Sciences (NASDAQ:GILD) versus Gritstone Oncology (NASDAQ:GRTS) Head to Head ComparisonGilead Sciences (NASDAQ:GILD) versus Gritstone Oncology (NASDAQ:GRTS) Head to Head Comparison
www.americanbankingnews.com - April 3 at 5:18 AM
Gritstone Oncology Inc (NASDAQ:GRTS) Short Interest Down 8.1% in MarchGritstone Oncology Inc (NASDAQ:GRTS) Short Interest Down 8.1% in March
www.americanbankingnews.com - March 29 at 8:20 PM
Gritstone Oncology Inc (NASDAQ:GRTS) Receives Average Rating of "Hold" from AnalystsGritstone Oncology Inc (NASDAQ:GRTS) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - March 23 at 5:50 AM
Critical Survey: Gritstone Oncology (NASDAQ:GRTS) vs. BIO-TECHNE (NASDAQ:TECH)Critical Survey: Gritstone Oncology (NASDAQ:GRTS) vs. BIO-TECHNE (NASDAQ:TECH)
www.americanbankingnews.com - March 23 at 4:27 AM
Gritstone Oncologys (GRTS) "Buy" Rating Reaffirmed at HC WainwrightGritstone Oncology's (GRTS) "Buy" Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - March 14 at 7:38 AM
Earnings Update: Gritstone Oncology, Inc. Just Reported And Analysts Are Boosting Their EstimatesEarnings Update: Gritstone Oncology, Inc. Just Reported And Analysts Are Boosting Their Estimates
finance.yahoo.com - March 13 at 4:10 PM
Gritstone Oncology (NASDAQ:GRTS) Releases Quarterly  Earnings Results, Misses Expectations By $0.08 EPSGritstone Oncology (NASDAQ:GRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS
www.americanbankingnews.com - March 12 at 11:54 AM
Gritstone Oncology EPS misses by $0.04, misses on revenueGritstone Oncology EPS misses by $0.04, misses on revenue
seekingalpha.com - March 11 at 1:55 PM
Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent HighlightsGritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
finance.yahoo.com - March 11 at 1:55 PM
Gritstone Oncology, Inc. (GRTS) Reports Q4 Loss, Misses Revenue EstimatesGritstone Oncology, Inc. (GRTS) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 11 at 1:55 PM
Gritstone Oncology to Present at Two Investor Conferences in MarchGritstone Oncology to Present at Two Investor Conferences in March
finance.yahoo.com - February 25 at 5:24 PM
Analysts: 3 Healthcare Stocks to Buy on Coronavirus WeaknessAnalysts: 3 Healthcare Stocks to Buy on Coronavirus Weakness
finance.yahoo.com - February 25 at 12:22 PM
Gritstone Oncology, Inc. (GRTS)Gritstone Oncology, Inc. (GRTS)
finance.yahoo.com - February 10 at 6:59 PM
Applied BioMath, LLC Announces Collaboration with Gritstone Oncology, Inc.Applied BioMath, LLC Announces Collaboration with Gritstone Oncology, Inc.
www.prnewswire.com - February 3 at 12:21 PM
Gritstone Oncology (GRTS) Presents At 38th Annual J.P. Morgan Healthcare Conference - SlideshowGritstone Oncology (GRTS) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 17 at 1:05 PM
Gritstone Oncology to Present at the 38th Annual J.P. Morgan Healthcare ConferenceGritstone Oncology to Present at the 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 8 at 8:43 PM
We Think Gritstone Oncology (NASDAQ:GRTS) Needs To Drive Business Growth CarefullyWe Think Gritstone Oncology (NASDAQ:GRTS) Needs To Drive Business Growth Carefully
finance.yahoo.com - January 1 at 4:13 PM
Is Gritstone Oncology, Inc. (GRTS) A Good Stock To Buy?Is Gritstone Oncology, Inc. (GRTS) A Good Stock To Buy?
finance.yahoo.com - December 16 at 8:07 AM
Gritstone down 15% on "promising" data on lead candidatesGritstone down 15% on "promising" data on lead candidates
seekingalpha.com - December 12 at 2:17 PM
Gritstone Oncology Reports Promising Early...Gritstone Oncology Reports Promising Early...
www.benzinga.com - December 12 at 8:42 AM
Gritstone Oncology to Webcast a Review of the Clinical Immunogenicity Data from its Neoantigen-based Immunotherapies that will be Presented at the ESMO Immuno-Oncology CongressGritstone Oncology to Webcast a Review of the Clinical Immunogenicity Data from its Neoantigen-based Immunotherapies that will be Presented at the ESMO Immuno-Oncology Congress
finance.yahoo.com - December 9 at 12:40 PM
Gritstone Oncology to Present at the Piper Jaffray Annual Healthcare ConferenceGritstone Oncology to Present at the Piper Jaffray Annual Healthcare Conference
finance.yahoo.com - November 26 at 3:59 PM
Gritstone Oncology EPS misses by $0.13, misses on revenueGritstone Oncology EPS misses by $0.13, misses on revenue
seekingalpha.com - November 12 at 12:30 PM
Gritstone Oncology Reports Third Quarter 2019 Financial Results and Recent HighlightsGritstone Oncology Reports Third Quarter 2019 Financial Results and Recent Highlights
finance.yahoo.com - November 12 at 12:30 PM
Gritstone Oncology, Inc. (GRTS) Reports Q3 Loss, Misses Revenue EstimatesGritstone Oncology, Inc. (GRTS) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 12 at 12:30 PM
Will Gritstone Oncology, Inc. (GRTS) Report Negative Q3 Earnings? What You Should KnowWill Gritstone Oncology, Inc. (GRTS) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - November 6 at 1:42 PM
Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE ImmunotherapyGritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy
finance.yahoo.com - November 5 at 8:28 AM
Gritstone Oncology to Webcast Investor Event Reviewing its Neoantigen-based Immunotherapies During SITC ConferenceGritstone Oncology to Webcast Investor Event Reviewing its Neoantigen-based Immunotherapies During SITC Conference
finance.yahoo.com - October 31 at 12:18 PM
Gritstone Oncology Announces Upcoming Presentation on Novel Shared Neoantigens Included within “Off-The-Shelf” SLATE Immunotherapy at SITC 2019 Annual MeetingGritstone Oncology Announces Upcoming Presentation on Novel Shared Neoantigens Included within “Off-The-Shelf” SLATE Immunotherapy at SITC 2019 Annual Meeting
finance.yahoo.com - October 7 at 8:08 AM
Investors Who Bought Gritstone Oncology (NASDAQ:GRTS) Shares A Year Ago Are Now Down 37%Investors Who Bought Gritstone Oncology (NASDAQ:GRTS) Shares A Year Ago Are Now Down 37%
finance.yahoo.com - September 27 at 8:44 AM
Gritstone Oncology to Present at Cantor Global Healthcare ConferenceGritstone Oncology to Present at Cantor Global Healthcare Conference
finance.yahoo.com - September 26 at 5:43 PM
Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V.Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V.
www.bloomberg.com - September 12 at 11:11 AM
Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. JonesGritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. Jones
finance.yahoo.com - September 12 at 11:11 AM
Gritstone Oncology (GRTS) Presents At Biotechnology Conference - SlideshowGritstone Oncology (GRTS) Presents At Biotechnology Conference - Slideshow
seekingalpha.com - August 14 at 3:50 PM
Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen ImmunotherapyGritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy
finance.yahoo.com - August 14 at 11:13 AM
Gritstone Oncology Reports Second Quarter 2019 Financial Results and Recent HighlightsGritstone Oncology Reports Second Quarter 2019 Financial Results and Recent Highlights
www.nasdaq.com - August 12 at 12:34 PM
Gritstone Oncology Reports Second Quarter 2019 Financial Results and Recent HighlightsGritstone Oncology Reports Second Quarter 2019 Financial Results and Recent Highlights
finance.yahoo.com - August 12 at 12:34 PM
Gritstone Oncology Announces the Appointment of Dr. Vijay Yabannavar, a Biopharma Leader with Over 30 Years of Experience, as Executive Vice President of Manufacturing and Technical OperationsGritstone Oncology Announces the Appointment of Dr. Vijay Yabannavar, a Biopharma Leader with Over 30 Years of Experience, as Executive Vice President of Manufacturing and Technical Operations
finance.yahoo.com - July 8 at 3:43 PM
bluebird bio: Returning To A Previous Winnerbluebird bio: Returning To A Previous Winner
seekingalpha.com - June 20 at 8:48 PM
Gritstone Oncology to Present at Two Upcoming Investor Conferences in JuneGritstone Oncology to Present at Two Upcoming Investor Conferences in June
finance.yahoo.com - June 5 at 11:48 AM
Health Care Digest: Why California biotech thrives, small company looks to crash NASH bash, meeting up at BIOHealth Care Digest: Why California biotech thrives, small company looks to crash NASH bash, meeting up at BIO
finance.yahoo.com - June 3 at 11:40 AM
Could Gritstone Oncology, Inc.'s (NASDAQ:GRTS) Investor Composition Influence The Stock Price?Could Gritstone Oncology, Inc.'s (NASDAQ:GRTS) Investor Composition Influence The Stock Price?
finance.yahoo.com - May 27 at 11:20 AM
Gritstone Oncology Reports First Quarter 2019 Financial Results and Recent HighlightsGritstone Oncology Reports First Quarter 2019 Financial Results and Recent Highlights
finance.yahoo.com - May 13 at 12:11 PM
Here’s What Hedge Funds Think About Gritstone Oncology, Inc. (GRTS)Here’s What Hedge Funds Think About Gritstone Oncology, Inc. (GRTS)
finance.yahoo.com - May 10 at 12:12 PM
Gritstone prices stock offering at $11.50; shares down 6% premarketGritstone prices stock offering at $11.50; shares down 6% premarket
seekingalpha.com - April 25 at 12:05 PM
Gritstone Oncology prices $74.8M equity offeringGritstone Oncology prices $74.8M equity offering
seekingalpha.com - April 25 at 12:05 PM
Why Gritstone Oncology Stock Is Sinking TodayWhy Gritstone Oncology Stock Is Sinking Today
finance.yahoo.com - April 25 at 12:05 PM
Gritstone Oncology Announces Proposed Public Offering of Common StockGritstone Oncology Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 23 at 11:46 AM
The Daily Biotech Pulse: FDA Accepts Alders Migraine Drug Application, Gritstone Offering, Lillys Chinese SaleThe Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale
finance.yahoo.com - April 23 at 11:46 AM
Biotech News Recap: Pressure On Shares Of Novartis Continues Following Zolgensma Patient DeathBiotech News Recap: Pressure On Shares Of Novartis Continues Following Zolgensma Patient Death
seekingalpha.com - April 22 at 3:38 PM
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel